Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Insys Therapeutics submits NDA for new oral formulation of dronabinol

Aug. 14, 2014

No Comments

Characterization of potential disease-causing mutations in tRNA genes

Aug. 14, 2014

No Comments

Amarantus Bioscience collaborates with the Buck Institute for Research on Aging

Aug. 13, 2014

No Comments

Oncothyreon to use Alpine's protocell technology for delivery of molecular therapeutics

Aug. 13, 2014

No Comments

Biodesy enters into research collaboration with Amgen

Aug. 12, 2014

No Comments

Sanofi licenses use of GLAAS platform to develop food allergy therapy

Aug. 12, 2014

No Comments

Perlstein Lab raises funds for orphan disease drug discovery

Aug. 12, 2014

No Comments

Genetic screening to identify novel small-molecule drug targets to overcome drug resistance

Aug. 12, 2014

No Comments

Valneva signs cell-line license agreement with GeoVax

Aug. 11, 2014

No Comments

Protein-modified red blood cells engineered to deliver systemic payloads

Aug. 11, 2014

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Insys Therapeutics submits NDA for new oral formulation of dronabinol

Characterization of potential disease-causing mutations in tRNA genes

Amarantus Bioscience collaborates with the Buck Institute for Research on Aging

Oncothyreon to use Alpine's protocell technology for delivery of molecular therapeutics

Biodesy enters into research collaboration with Amgen

Sanofi licenses use of GLAAS platform to develop food allergy therapy

Perlstein Lab raises funds for orphan disease drug discovery

Genetic screening to identify novel small-molecule drug targets to overcome drug resistance

Valneva signs cell-line license agreement with GeoVax

Protein-modified red blood cells engineered to deliver systemic payloads

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS